इमेजिंग और रेडियोलॉजी
प्रकाशितAI-supported reading in the MASAI mammography trial
The MASAI trial in Sweden randomly assigned screening mammograms to AI-supported reading or standard double reading without AI. Transpara scored each exam and routed lower scores to a single reader and the highest score to double reading, with detection marks available on higher-risk exams. This card quotes the prespecified interim safety analysis, not a claim that every screening program should switch.
Transpara 1.7.0 · ScreenPoint Medical